BRUSSELS, Belgium—ExciPact, an international non-profit organization that provides voluntary third-party GMP certification to excipient manufacturers, has certified JRS Pharma’s manufacturing site in Gujarat, India. The certification demonstrates that the site manufactures microcrystalline cellulose according to ExciPact’s GMP standards. Due to Covid-19 travel restrictions, these certificates offer customers risk assessment assurance without the need to travel.